Walker Barrier Systems Builds Mobile Clean Rooms for Texas A&M University System Facility

Walker Barrier Systems Builds Mobile Clean Rooms for Texas A&M University
System Facility

NEW LISBON, Wis., March 11, 2014 (GLOBE NEWSWIRE) -- Walker Barrier Systems, a
producer of isolation and containment equipment within Wabash National
Corporation's (NYSE:WNC) Walker Group division, announced today that it has
built and delivered the first of eight mobile clean rooms for the Texas A&M
Center for Innovation in Advanced Development and Manufacturing (CIADM).
Walker Barrier Systems has more than 20 years of experience providing
isolation equipment to more than 100 companies in the pharmaceutical and
biotechnology industries.

"The ability to leverage Walker Barrier Systems' position as the leading brand
of containment and isolation technologies will provide the highest quality,
best value products and enhance the Texas A&M CIADM initiatives to establish
flexible manufacturing capabilities," said Dr. Gerald Parker, CIADM principal

The Texas A&M Center for Innovation is home to the National Center for
Therapeutics Manufacturing (NCTM), which provides a flexible facility
architecture for the development and production of vaccines and therapeutics
for use in clinical trials. This adaptability is achieved using mobile clean
rooms, which are small, self-contained laboratories configured for individual
manufacturing processes. This technology represents a major breakthrough for
the manufacture of drugs and therapeutics, as mobile clean rooms provide
completely isolated and contained environments that enable multiple
therapeutics to be manufactured simultaneously in a single facility. The
addition of eight new mobile clean rooms to the NCTM will greatly enhance the
facility and the development and manufacturing capacity of the CIADM.

The Walker Barrier Systems mobile clean room design will allow the NCTM to
manufacture clinical grade materials at enhanced levels of compliance. Walker
Barrier Systems units, constructed with Wabash National's DuraPlate® composite
panel technology, are built to support a broad array of processes and
platforms that will be required by CIADM to manufacture biosecurity medical

"While mobile, these clean rooms are approximately 48 feet long and 18 feet
wide, providing full-scale manufacturing capabilities," said Dave Nick, vice
president and general manager of Walker Group Engineered Products. "In
addition, they are designed to be joined together to create larger suites to
fit specific application requirements. The mobile clean rooms bring together
Walker Barriers Systems' leading solutions in isolation and containment into a
rapidly deployable and flexible manufacturing facility."

Construction of the mobile clean rooms began in May 2013, and all eight are
expected to be in operation at the NCTM by early 2014. The first unit was
delivered in January 2014.

Learn more about Walker Barrier Systems' mobile clean rooms at the
International Pharmaceutical Expo (INTERPHEX) March 18–20, 2014, in New York

About Wabash National Corporation

Headquartered in Lafayette, Ind., Wabash National Corporation (NYSE:WNC) is a
diversified industrial manufacturer and North America's leading producer of
semi-trailers and liquid transportation systems. Established in 1985, the
company specializes in the design and production of dry freight vans,
refrigerated vans, platform trailers, liquid tank trailers, intermodal
equipment, engineered products and composite products. Its innovative products
are sold under the following brand names: Wabash National®, Transcraft®,
Benson®, DuraPlate®, Walker Transport, Walker Defense Group, Walker Barrier
Systems, Walker Engineered Products, Brenner® Tank, Beall®, Garsite, Progress
Tank, TST®, Bulk Tank International and Extract Technology®. To learn more,
visit www.wabashnational.com.

About the Texas A&M Center for Innovation

The Texas A&M Center for Innovation in Advance Development and Manufacturing
(CIADM) is one of three centers established in June, 2012 by the US Department
of Health and Human Services to enhance the nation's emergency preparedness
against emerging infectious diseases, including pandemic influenza, and
chemical, biological, radiological and nuclear threats. The Center is founded
on an initial $285.6 million investment, including a $176.6 million
contribution from the US Department of Health and Human Services, with the
remainder cost-shared by commercial and academic proposal partners. The Center
will perform research and advanced development to accelerate vaccines and
other medical products through pre-clinical and clinical development and
produce these products in cases of pandemics or other national emergencies.
Through these activities, the Center will address a recognized shortcoming in
preparedness and response to known and unknown threats, and will improve our
nation's ability to protect the health of its citizens in emergency

CONTACT: Media Contact:
         Dana Stelsel
         (765) 771-5766
         Media Contact:
         Patricia Haigwood
         (979) 436-9106

company logo
Press spacebar to pause and continue. Press esc to stop.